. Author manuscript; available in PMC: 2015 Oct 1.

Published in final edited form as: Crit Care Med. 2014 Oct;42(10):2244–2251. doi: 10.1097/CCM.0000000000000522

Table 1. Demographics and clinical characteristics ^*.

Variable	Cohort, n=69
Age	57 (46-68) ^a
Female (%, n/total)	48% (33/69)
Race (%, n/total)
Black/African American	14% (10/69)
White	86% (59/69)
APACHE II	26.0 (20.2-32.0) ^a
ICU admission diagnosis (%, n/total)
Sepsis/acute respiratory distress syndrome	35% (24/69)
Surgery	29% (20/69)
Airway protection/upper airway obstruction	13% (9/69)
Myocardial infarction/congestive heart failure	9% (6/69)
GI bleed/hemorrhagic shock	4% (3/69)
Other	10% (7/69)
Total Lorazepam (mg)	7 [0.8-64]
Total Fentanyl (mcg)	5375 [1150-12350]
Total Propofol (mg)	0 [0-3291]
Time in burst suppression, minutes	6.4 (1.0-58.0) ^a
Time under BIS of 40, minutes	67 (2-827) ^a
Post-coma delirium, (%, n/total)	61% (42/69)
Time to resolution of delirium, hours	25 (0-71) ^a,^b

Median (interquartile range)

Results for the 49 patients who had resolution of delirium during the study period (n=22) or were never delirious (n=27).

Abbreviations: APACHE = Acute Physiology and Chronic Health Evaluation severity of illness score; BIS = Bispectral Index fronto-temporal EEG monitor, GI = gastrointestinal; ICU = Intensive Care Unit

Table 1. Demographics and clinical characteristics *.

Table 1. Demographics and clinical characteristics ^*.